世界の臨床微生物市場2023-2030:製品別、疾患別(血流、呼吸器、消化器、歯周病、STD、UTI)、地域別

【英語タイトル】Clinical Microbiology Market Size, Share & Trends Analysis Report By Product, By Disease (Bloodstream, Respiratory, Gastrointestinal, Periodontal, STD, UTI), By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23NOV075)・商品コード:GRV23NOV075
・発行会社(調査会社):Grand View Research
・発行日:2023年9月
・ページ数:94
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:バイオ
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

臨床微生物市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界の臨床微生物市場規模は2030年までに76億米ドルに達し、予測期間中のCAGRは7.1%を記録する見込みです。予測期間中のCAGRは6.7%で拡大すると予測されています。臨床微生物は、臨床検体の処理と結果の解釈のために技術的かつ熟練した労働力に依存しています。臨床スタッフは、検査のTAT(Turnaround Time:所要時間)が短いことに不満を抱いてきました。しかし、技術の進歩に伴い、多くの検査機器や装置が自動化された装置に置き換えられ、人的エラーや熟練労働者への依存を最小限に抑えています。

さらに、自動化には、TATの短縮、労働力とラボスペースの使用削減などの利点があり、それによってこれらの検査に関連する全体的なコストを削減することができます。各メーカーは、自動検体処理、プレート読み取り、生物同定の導入に注力しています。GE Healthcare、PerkinElmer、Thermo Fisherは、診断業界で自動化システムを提供している主要企業の一部です。

院内感染(HAI)の増加も、診断とモニタリングのための臨床微生物検査の需要を促進しています。高所得国が院内感染対策を強化する中、中低所得国もその脅威を認識しています。自動化システムと革新的な設計の導入により、市場競争が激化し、予測期間中に市場ダイナミクスが変化することが予想されます。

世界保健機関(WHO)は、エチオピア、ブルキナファソ、ナイジェリア、アルジェリア、セネガルなど、HAIの発生率が2.5%~14.8%の国々で特に積極的に活動しています。このため、これらの国々ではHAI診断薬に対する需要が高まっています。インド、スリランカ、パキスタン、ブータンなどの国々も、HAI啓発プログラムに積極的に参加しています。インドと中国は今後、HAI診断機器と検査の需要を牽引する主要国になると予測されています。

臨床微生物市場レポートハイライト

- 予測期間中、分子診断機器分野が最も速い成長率を示すと予測されています。この成長の背景には、がんや感染症の早期発見における分子診断の重要性が高まっていることがあります。

- 試薬は繰り返し購入されるため、2022年に最大の収益シェアを獲得しました。

- 2022年、北米が世界市場を席巻。感染症治療に関する継続的な研究と、それに続く政府医療機関からの助成金が、同地域の強力なエコシステムの発展に貢献します。

- アジア太平洋地域は、インド、中国、日本における高齢者人口の増加により、予測期間中に最も急成長する地域となる見込みです。その結果、結核、コレラ、腸チフスなどの再興感染症が多発しています。

第1章 調査方法・範囲
第2章 エグゼクティブサマリー
第3章 世界の臨床微生物市場変数・傾向・範囲
第4章 世界の臨床微生物市場:製品別予測・傾向分析
第5章 世界の臨床微生物市場:疾患別予測・傾向分析
第6章 世界の臨床微生物市場:地域別予測・傾向分析
第7章 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Disease
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Disease outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Clinical Microbiology Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Clinical Microbiology Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Clinical Microbiology : Product Estimates & Trend Analysis
4.1. Clinical Microbiology Market: Key Takeaways
4.2. Clinical Microbiology Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Laboratory Instruments
4.3.1. Laboratory instruments market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Incubators
4.3.2.1. Incubators market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Gram stainers
4.3.3.1. Gram stainers market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. Bacterial colony counters
4.3.4.1. Bacterial colony counters market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.5. Autoclave sterilizers
4.3.5.1. Autoclave sterilizers market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.6. Petri dish fillers
4.3.6.1. Petri dish fillers market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Automated Culture
4.4.1. Automated culture market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.2. Microbiology analyzers
4.4.2.1. Microbiology analyzers market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.3. Molecular diagnostic instruments
4.4.3.1. Molecular diagnostic instruments market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.4. Microscopes
4.4.4.1. Microscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.4.5. Mass spectrometers
4.4.5.1. Mass spectrometers market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Reagents
4.5.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Clinical Microbiology: Disease Estimates & Trend Analysis
5.1. Clinical Microbiology Market: Key Takeaways
5.2. Clinical Microbiology Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Respiratory Diseases
5.3.1. Respiratory diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Bloodstream Infections
5.4.1. Bloodstream infections market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Gastrointestinal Diseases
5.5.1. Gastrointestinal diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Sexually Transmitted Diseases
5.6.1. Sexually transmitted diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Urinary Tract Infections
5.7.1. Urinary tract infections market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Periodontal Diseases
5.8.1. Periodontal diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Other Diseases
5.9.1. Other diseases market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Clinical Microbiology Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Clinical Microbiology Market by Region: Key Takeaways
6.3. North America
6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. U.S.
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. Canada
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4. Europe
6.4.1. UK
6.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.2. Germany
6.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.3. France
6.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.4. Italy
6.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.5. Spain
6.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.6. Denmark
6.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.7. Sweden
6.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.4.8. Norway
6.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5. Asia Pacific
6.5.1. Japan
6.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.2. China
6.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.3. India
6.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.4. Australia
6.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.5. Thailand
6.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.5.6. South Korea
6.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6. Latin America
6.6.1. Brazil
6.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.2. Mexico
6.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.6.3. Argentina
6.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7. MEA
6.7.1. South Africa
6.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.3. UAE
6.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.7.4. Kuwait
6.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. BIOMÉRIEUX
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Cepheid.
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Danaher Corporation
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Bruker Corporation
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. BD
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Hologic, Inc.
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. F. Hoffmann-La Roche Ltd
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Alere, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 3 North America clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 4 North America clinical microbiology market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 7 Canada clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 8 Canada clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 9 Europe clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 10 Europe clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 11 Europe clinical microbiology market, by region, 2018 - 2030 (USD Million)
Table 12 Germany clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 13 Germany clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 14 UK clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 15 UK clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 16 France clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 17 France clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 18 Italy clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 19 Italy clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 20 Spain clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 21 Spain clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 22 Denmark clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 23 Denmark clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 24 Sweden clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 25 Sweden clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 26 Norway clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 27 Norway clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 28 Asia Pacific clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 29 Asia Pacific clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 30 Asia Pacific clinical microbiology market, by region, 2018 - 2030 (USD Million)
Table 31 Japan clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 32 Japan clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 33 China clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 34 China clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 35 India clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 36 India clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 37 Australia clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 38 Australia clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 39 Thailand clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 40 Thailand clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 41 South Korea clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 42 South Korea clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 43 Latin America clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 44 Latin America clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 45 Latin America clinical microbiology market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 48 Mexico clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 50 Argentina clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa clinical microbiology market, by region, 2018 - 2030 (USD Million)
Table 55 South Africa clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 56 South Africa clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 57 Saudi Arabia clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 58 Saudi Arabia clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 59 UAE clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 60 UAE clinical microbiology market, by disease, 2018 - 2030 (USD Million)
Table 61 Kuwait clinical microbiology market, by product, 2018 - 2030 (USD Million)
Table 62 Kuwait clinical microbiology market, by disease, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Clinical Microbiology: Market outlook
Fig. 9 Clinical Microbiology: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Clinical microbiology market driver impact
Fig. 15 Clinical microbiology market restraint impact
Fig. 16 Clinical microbiology market strategic initiatives analysis
Fig. 17 Clinical microbiology market: Product movement analysis
Fig. 18 Clinical microbiology market: product outlook and key takeaways
Fig. 19 Laboratory instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Gram stainers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Bacterial colony counters market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Autoclave sterilizers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Petri dish fillers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Automated culture systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Microbiology analyzers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Molecular diagnostic instruments market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Microscopes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Mass spectrometers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Clinical microbiology market: Disease movement analysis
Fig. 32 Clinical microbiology market: disease outlook and key takeaways
Fig. 33 Respiratory diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Bloodstream infections market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Gastrointestinal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Sexually transmitted diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Urinary tract infections market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Periodontal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Other diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Global clinical microbiology market: Regional movement analysis
Fig. 41 Global clinical microbiology market: Regional outlook and key takeaways
Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

★調査レポート[世界の臨床微生物市場2023-2030:製品別、疾患別(血流、呼吸器、消化器、歯周病、STD、UTI)、地域別] (コード:GRV23NOV075)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の臨床微生物市場2023-2030:製品別、疾患別(血流、呼吸器、消化器、歯周病、STD、UTI)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆